Colonoscopy screening numbers starting to rebound (Becker’s GI & Endoscopy)
COVID-19 severely affected colonoscopies because of the high risk of transmission, but Pittsburgh-based Allegheny Health Network said screening numbers were beginning to rebound.
AI appears headed for the endoscopy suite (AI in Healthcare)
Nearly 90% of U.S. gastroenterologists are open to using AI for help performing high quality colonoscopies.
Exact Sciences extends profitable Pfizer marketing agreement (Becker’s GI & Endoscopy)
Since partnering with Pfizer in 2018, Exact Sciences has screened more than 3 million people, and more than 90,000 providers ordered Cologuard for the first time.
Gastro Health begins offering CapsoCam at home (Becker’s GI & Endoscopy)
Following the FDA’s labeling change, Miami-based Gastro Health now offers patients access to CapsoCam Plus treatments at home.
Endoscopy Insights With Dr. Prateek Sharma (Gastroenterology & Endoscopy News)
Dr. Sharma, discusses two abstracts submitted to the Digestive Disease Week 2020, and a recently published article examining the role of AI in the endoscopy suite.
AI in GI ‘will have durable impact on the practice of medicine’ (Healio)
Sidhartha Sinha, MD, from the division of gastroenterology and hepatology at Stanford Medicine, highlighted advances in technology that will transform the way physicians practice medicine.
Proton Pump Inhibitors Tied to COVID-19 Risk (Medscape)
In light of this finding, physicians should consider which patients truly need these powerful acid-lowering drugs, said Brennan Spiegel, MD, MSHS.
The Regueiro Report: Going Digital With IBD (Gastroenterology & Endoscopy News)
According to co-principal investigator Ashish Atreja, MD, at Mount Sinai, patients who have IBD like using digital tools.
COVID-19: The Way Forward for Gastroenterology Practices
COVID-19 is a double whammy of both clinical and business disruption. This ebook will help you explore possible scenarios and be a guide in your plans for the future.